315 related articles for article (PubMed ID: 33645311)
1. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.
Inserra A; De Gregorio D; Rezai T; Lopez-Canul MG; Comai S; Gobbi G
J Psychopharmacol; 2021 Apr; 35(4):469-482. PubMed ID: 33645311
[TBL] [Abstract][Full Text] [Related]
2. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
[TBL] [Abstract][Full Text] [Related]
3. Effective connectivity changes in LSD-induced altered states of consciousness in humans.
Preller KH; Razi A; Zeidman P; Stämpfli P; Friston KJ; Vollenweider FX
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2743-2748. PubMed ID: 30692255
[TBL] [Abstract][Full Text] [Related]
4. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
Elife; 2018 Oct; 7():. PubMed ID: 30355445
[TBL] [Abstract][Full Text] [Related]
5. Gating of hippocampal-evoked activity in prefrontal cortical neurons by inputs from the mediodorsal thalamus and ventral tegmental area.
Floresco SB; Grace AA
J Neurosci; 2003 May; 23(9):3930-43. PubMed ID: 12736363
[TBL] [Abstract][Full Text] [Related]
6. Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration.
Avram M; Müller F; Preller KH; Razi A; Rogg H; Korda A; Holze F; Vizeli P; Ley L; Liechti ME; Borgwardt S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):522-532. PubMed ID: 37532129
[TBL] [Abstract][Full Text] [Related]
7. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.
De Gregorio D; Inserra A; Enns JP; Markopoulos A; Pileggi M; El Rahimy Y; Lopez-Canul M; Comai S; Gobbi G
Neuropsychopharmacology; 2022 May; 47(6):1188-1198. PubMed ID: 35301424
[TBL] [Abstract][Full Text] [Related]
8. Prefrontal cortex modulates firing pattern in the nucleus reuniens of the midline thalamus via distinct corticothalamic pathways.
Zimmerman EC; Grace AA
Eur J Neurosci; 2018 Nov; 48(10):3255-3272. PubMed ID: 30107061
[TBL] [Abstract][Full Text] [Related]
9. d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex.
Reissig CJ; Rabin RA; Winter JC; Dlugos CA
Eur J Pharmacol; 2008 Mar; 583(1):40-7. PubMed ID: 18262520
[TBL] [Abstract][Full Text] [Related]
10. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
11. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
Arvanov VL; Liang X; Russo A; Wang RY
Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
[TBL] [Abstract][Full Text] [Related]
12. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.
De Gregorio D; Popic J; Enns JP; Inserra A; Skalecka A; Markopoulos A; Posa L; Lopez-Canul M; Qianzi H; Lafferty CK; Britt JP; Comai S; Aguilar-Valles A; Sonenberg N; Gobbi G
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495318
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration.
Nichols CD; Garcia EE; Sanders-Bush E
Brain Res Mol Brain Res; 2003 Mar; 111(1-2):182-8. PubMed ID: 12654518
[TBL] [Abstract][Full Text] [Related]
14. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Marona-Lewicka D; Thisted RA; Nichols DE
Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.
Avram M; Müller F; Rogg H; Korda A; Andreou C; Holze F; Vizeli P; Ley L; Liechti ME; Borgwardt S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Sep; 7(9):885-894. PubMed ID: 35500840
[TBL] [Abstract][Full Text] [Related]
16. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
Gresch PJ; Strickland LV; Sanders-Bush E
Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
[TBL] [Abstract][Full Text] [Related]
17. The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex.
Gronier B; Waters S; Ponten H
J Neural Transm (Vienna); 2013 Sep; 120(9):1281-94. PubMed ID: 23468085
[TBL] [Abstract][Full Text] [Related]
18. Anterolateral Motor Cortex Connects with a Medial Subdivision of Ventromedial Thalamus through Cell Type-Specific Circuits, Forming an Excitatory Thalamo-Cortico-Thalamic Loop via Layer 1 Apical Tuft Dendrites of Layer 5B Pyramidal Tract Type Neurons.
Guo K; Yamawaki N; Svoboda K; Shepherd GMG
J Neurosci; 2018 Oct; 38(41):8787-8797. PubMed ID: 30143573
[TBL] [Abstract][Full Text] [Related]
19. Early lesion of the reticular thalamic nucleus disrupts the structure and function of the mediodorsal thalamus and prefrontal cortex.
El Boukhari H; Ouhaz Z; Ba-M'hamed S; Bennis M
Dev Neurobiol; 2019 Nov; 79(11-12):913-933. PubMed ID: 31976624
[TBL] [Abstract][Full Text] [Related]
20. Disinhibition of the mediodorsal thalamus induces fos-like immunoreactivity in both pyramidal and GABA-containing neurons in the medial prefrontal cortex of rats, but does not affect prefrontal extracellular GABA levels.
Bubser M; de Brabander JM; Timmerman W; Feenstra MG; Erdtsieck-Ernste EB; Rinkens A; van Uum JF; Westerink BH
Synapse; 1998 Oct; 30(2):156-65. PubMed ID: 9723785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
